GlassScriptPhysician profile
Robert Gene Parker
NPI 1740381771
$5,129.09
in general payments reported to CMS, 2019-2025
22 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $2,108 · 2021: $240 · 2022: $1,994 · 2023: $318 · 2024: $105 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,163.52 | 2020-2021 | |
| Anika Therapeutics, INC. | $1,200.35 | 2022 | |
| Stimwave Technologies Incorporated | $400.00 | 2022 | |
| Bioventus LLC | $181.01 | 2019-2022 | |
| Cook Medical LLC | $160.71 | 2023 | Zilver Vena |
| Grt US Holding, INC. | $153.00 | 2021-2022 | |
| Medtronic, INC. | $142.62 | 2023-2024 | Hawkone, Vanta Adaptivestim |
| Axogen | $99.53 | 2022-2025 | Avance Nerve Graft |
| Novo Nordisk INC | $92.71 | 2022 | |
| Checkpoint Surgical, INC | $87.43 | 2022 | |
| Integra Lifesciences Corporation | $63.53 | 2021-2025 | Tenoglide, Neuragen |
| Stryker Corporation | $61.48 | 2019 | |
| Medinc of Texas | $60.41 | 2024 | |
| Spinesmith Holdings, LLC | $50.97 | 2019 | |
| Organogenesis INC. | $50.59 | 2025 | Via Matrix, Affinity |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $41.49 | 2025 | |
| Mimedx Group, INC. | $27.78 | 2025 | |
| Ibsa Pharma INC. | $22.92 | 2024 | Licart, Tirosint |
| Acell, INC. | $21.30 | 2019 | |
| Lifenet Health | $16.47 | 2025 | Theragenesis Wound Matrix |
| Assertio Therapeutics, INC. | $16.16 | 2020 | |
| Merck Sharp & Dohme LLC | $15.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.